STEK (Stemtech) EPS (Basic) : $-0.06 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stemtech EPS (Basic)?

Stemtech's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was $-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.06.

Stemtech's EPS (Diluted) for the three months ended in Sep. 2024 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.06.

Stemtech's EPS without NRI for the three months ended in Sep. 2024 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.06.

During the past 3 years, the average EPS without NRI Growth Rate was -70.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Stemtech's highest 3-Year average EPS without NRI Growth Rate was -70.50% per year. The lowest was -70.50% per year. And the median was -70.50% per year.

Stemtech EPS (Basic) Historical Data

The historical data trend for Stemtech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech EPS (Basic) Chart

Stemtech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.03

-0.20

-0.19

-0.07

Stemtech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial												-0.01	-0.02	-0.02	-0.01	-0.01

Stemtech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Stemtech's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.43	-	0)	/	83.470
	=	-0.07

Stemtech's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.17	-	0)	/	120.570
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06

Stemtech (OTCPK:STEK) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Stemtech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Stemtech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Stemtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103

Website

https://www.stemtech.com

Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.

Executives

Charles Stuart Arnold	director	520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc.	10 percent owner	419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green	director	300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer	director	10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan	director	13005 CORONOADO LANE, NORTH MIAMI FL 33181